Decitabine for Treatment of Myelodysplastic Syndromes in Chinese Patients: An Open-Label, Phase-3b Study | |
Wu, Depei; Du, Xin; Jin, Jie; Xiao, Zhijian; Shen, Zhixiang; Shao, Zonghong; Li, Xiao; Huang, Xiaojun; Liu, Ting; Yu, Li | |
2015 | |
卷号 | 32期号:11页码:1140-1159 |
关键词 | Chinese population Decitabine Hematology Myelodysplastic syndrome (MDS) Oncology Phase 3b |
ISSN号 | 0741-238X |
DOI | 10.1007/s12325-015-0263-8 |
URL标识 | 查看原文 |
收录类别 | SCIE |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/6663666 |
专题 | 中国医学科学院 北京协和医学院 |
推荐引用方式 GB/T 7714 | Wu, Depei,Du, Xin,Jin, Jie,et al. Decitabine for Treatment of Myelodysplastic Syndromes in Chinese Patients: An Open-Label, Phase-3b Study[J],2015,32(11):1140-1159. |
APA | Wu, Depei.,Du, Xin.,Jin, Jie.,Xiao, Zhijian.,Shen, Zhixiang.,...&Ruan, Changgeng.(2015).Decitabine for Treatment of Myelodysplastic Syndromes in Chinese Patients: An Open-Label, Phase-3b Study.,32(11),1140-1159. |
MLA | Wu, Depei,et al."Decitabine for Treatment of Myelodysplastic Syndromes in Chinese Patients: An Open-Label, Phase-3b Study".32.11(2015):1140-1159. |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论